Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Freeslate, Inc. Partners With J & J to Deliver Enhanced Pharmaceutical Research Products and Services

By Pharmaceutical Processing | April 28, 2010

Freeslate, Inc. has entered into a strategic partnership with Johnson & Johnson Pharmaceutical Research & Development, LLC (J&JPRD, LLC.) to deliver integrated workflows, software, and pharmaceutical research services thru 2012.  These products and services are specifically designed to deliver step-change gains in productivity and innovation, impacting both large and small molecule drug development.

“This strategic partnership demonstrates both the breadth and depth of Freeslate’s expertise in deploying industry-leading solutions to pharmaceutical research organizations,” said John Senaldi, chief executive officer of Freeslate. “We are excited to further our success in helping our customers make better decisions earlier in the drug development process.”

Freeslate’s new workflow tools are built on its recently-launched, modular CM3 platform to impact small molecule drug product development, biological drug substance development, and biological formulation development and testing.  In addition to delivering Freeslate’s Laboratory Execution and Analysis (LEA) software to power these tools, the company will be deploying the LEA suite of software to integrate a number of existing workflows.

 

Related Articles Read More >

Great Point Partners logo.
Great Point Partners acquires majority stake in Eutecma to fuel sustainable cold chain growth
Driving success in fast-paced high-tech pharma construction projects
This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE